230 related articles for article (PubMed ID: 16472623)
21. Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
Ciocan D; Voican CS; Barbu V; Corpechot C; Rainteau D; Prevot S; Lebrun A; Perlemuter G
Am J Gastroenterol; 2019 Sep; 114(9):1556-1559. PubMed ID: 31335361
[No Abstract] [Full Text] [Related]
22. [Intrahepatic cholestasis in pregnancy treated with ursodeoxycholic acid].
Grønlund LA
Ugeskr Laeger; 1999 Sep; 161(39):5433-4. PubMed ID: 10553357
[TBL] [Abstract][Full Text] [Related]
23. Fetal death in a patient with intrahepatic cholestasis of pregnancy.
Sentilhes L; Verspyck E; Pia P; Marpeau L
Obstet Gynecol; 2006 Feb; 107(2 Pt 2):458-60. PubMed ID: 16449148
[TBL] [Abstract][Full Text] [Related]
24. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
[TBL] [Abstract][Full Text] [Related]
25. Pruritus in pregnancy.
Orr B; Usatine RP
J Fam Pract; 2007 Nov; 56(11):913-6. PubMed ID: 17976338
[No Abstract] [Full Text] [Related]
26. Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy?
Chappell LC; Chambers J; Thornton JG; Williamson C
BMJ; 2018 Feb; 360():k104. PubMed ID: 29419378
[No Abstract] [Full Text] [Related]
27. Ursofalk.
Williams CN
Can J Gastroenterol; 1999 Nov; 13(9):717-8. PubMed ID: 10633823
[No Abstract] [Full Text] [Related]
28. A prolonged gestational intrahepatic cholestasis: a case report.
Aytaç S; Kargili A; Türkay C
Turk J Gastroenterol; 2006 Sep; 17(3):206-8. PubMed ID: 16941255
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic cholestasis and eclampsia: a case report.
Atabey S; Duvan CI; Eren U; Turhan NO
Hypertens Pregnancy; 2007; 26(4):363-9. PubMed ID: 18066956
[TBL] [Abstract][Full Text] [Related]
30. Prolonged cholestasis due to hepatitis A virus infection.
Kumar P; Bhatia V
Indian Pediatr; 2011 Jun; 48(6):485-6. PubMed ID: 21743116
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
32. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase.
Cançado EL; Leitão RM; Carrilho FJ; Laudanna AA
Am J Gastroenterol; 1998 Sep; 93(9):1510-7. PubMed ID: 9732934
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome in cases of intrahepatic cholestasis of pregnancy.
Baliutavičienė D; Zubruvienė N; Zalinkevičius R
Int J Gynaecol Obstet; 2011 Mar; 112(3):250-1. PubMed ID: 21247575
[No Abstract] [Full Text] [Related]
34. Genetic cholestasis.
Jansen PL; Sturm E
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S107-9. PubMed ID: 12817339
[No Abstract] [Full Text] [Related]
35. Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.
Lykavieris P; Bernard O; Jacquemin E
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101472. PubMed ID: 32565202
[No Abstract] [Full Text] [Related]
36. [Treatment of primary biliary cirrhosis].
Szalay F
Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
[No Abstract] [Full Text] [Related]
37. Cholestatic liver disease in long-term infantile nephropathic cystinosis.
Cornelis T; Claes K; Gillard P; Nijs E; Roskams T; Lombaerts R; Nevens F; Cassiman D
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e428-31. PubMed ID: 18466290
[TBL] [Abstract][Full Text] [Related]
38. Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases.
Katsinelos P; Vasiliadis T; Xiarchos P; Patakiouta F; Christodoulou K; Pilpilidis I; Eugenidis N
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):365-8. PubMed ID: 10750660
[TBL] [Abstract][Full Text] [Related]
39. Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans.
Marschall HU; Wagner M; Zollner G; Fickert P; Silbert D; Gustafsson U; Sahlin S; Trauner M
Digestion; 2012; 86(3):244-9. PubMed ID: 22964716
[TBL] [Abstract][Full Text] [Related]
40. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
